Mesenchymal stem cells

Stem cells
#CDMO #Clinical trials #Drug delivery #EXO Biologics #Exosomes #ExoXpert #Mesenchymal stem cells

CDMO launched to service increasing demand for exosomes 

EXO Biologics has launched ExoXpert, a contract development and manufacturing organisation (CDMO) specialising in exosomes which offers a mesenchymal stem cells (MSC)-based exosome manufacturing platform used in European clinical trials.  During the development of its lead exosome candidate, EXOB-001, Exo Biologics developed ExoPulse, an industrial exosome manufacturing… Read More

#News

Paris
#Cell and gene therapy #Events #ISCT #Mesenchymal stem cells #new generation MSCs

ISCT 2023 key trends: new generation MSCs  

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. The ISCT 2023 Annual Meeting took place in Paris, France… Read More

#Exclusive Content